| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: A0A3S5H6Z6
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 1 |
| GO:0005488 | binding | 1 | 1 |
| GO:0097159 | organic cyclic compound binding | 2 | 1 |
| GO:1901363 | heterocyclic compound binding | 2 | 1 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 186 | 190 | PF00656 | 0.673 |
| CLV_C14_Caspase3-7 | 35 | 39 | PF00656 | 0.597 |
| CLV_NRD_NRD_1 | 21 | 23 | PF00675 | 0.727 |
| CLV_NRD_NRD_1 | 227 | 229 | PF00675 | 0.715 |
| CLV_NRD_NRD_1 | 89 | 91 | PF00675 | 0.582 |
| CLV_NRD_NRD_1 | 98 | 100 | PF00675 | 0.634 |
| CLV_PCSK_KEX2_1 | 21 | 23 | PF00082 | 0.642 |
| CLV_PCSK_KEX2_1 | 227 | 229 | PF00082 | 0.715 |
| CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.545 |
| CLV_PCSK_KEX2_1 | 88 | 90 | PF00082 | 0.558 |
| CLV_PCSK_KEX2_1 | 98 | 100 | PF00082 | 0.595 |
| CLV_PCSK_PC1ET2_1 | 84 | 86 | PF00082 | 0.613 |
| CLV_PCSK_PC1ET2_1 | 98 | 100 | PF00082 | 0.559 |
| CLV_PCSK_PC7_1 | 223 | 229 | PF00082 | 0.720 |
| CLV_PCSK_PC7_1 | 85 | 91 | PF00082 | 0.675 |
| CLV_PCSK_SKI1_1 | 100 | 104 | PF00082 | 0.618 |
| CLV_PCSK_SKI1_1 | 168 | 172 | PF00082 | 0.632 |
| CLV_PCSK_SKI1_1 | 211 | 215 | PF00082 | 0.638 |
| CLV_PCSK_SKI1_1 | 227 | 231 | PF00082 | 0.538 |
| CLV_PCSK_SKI1_1 | 59 | 63 | PF00082 | 0.558 |
| DEG_SCF_FBW7_1 | 108 | 115 | PF00400 | 0.639 |
| DOC_CYCLIN_RxL_1 | 18 | 29 | PF00134 | 0.656 |
| DOC_CYCLIN_RxL_1 | 97 | 106 | PF00134 | 0.650 |
| DOC_CYCLIN_yCln2_LP_2 | 30 | 36 | PF00134 | 0.663 |
| DOC_MAPK_MEF2A_6 | 199 | 206 | PF00069 | 0.734 |
| DOC_PP1_RVXF_1 | 19 | 26 | PF00149 | 0.619 |
| DOC_PP2B_LxvP_1 | 30 | 33 | PF13499 | 0.631 |
| DOC_USP7_MATH_1 | 112 | 116 | PF00917 | 0.729 |
| DOC_USP7_MATH_1 | 51 | 55 | PF00917 | 0.635 |
| DOC_USP7_UBL2_3 | 205 | 209 | PF12436 | 0.628 |
| DOC_WW_Pin1_4 | 108 | 113 | PF00397 | 0.620 |
| LIG_14-3-3_CanoR_1 | 22 | 28 | PF00244 | 0.701 |
| LIG_BIR_III_4 | 191 | 195 | PF00653 | 0.663 |
| LIG_BRCT_BRCA1_1 | 53 | 57 | PF00533 | 0.678 |
| LIG_deltaCOP1_diTrp_1 | 46 | 56 | PF00928 | 0.581 |
| LIG_FHA_1 | 138 | 144 | PF00498 | 0.674 |
| LIG_FHA_2 | 120 | 126 | PF00498 | 0.660 |
| LIG_FHA_2 | 129 | 135 | PF00498 | 0.541 |
| LIG_FHA_2 | 179 | 185 | PF00498 | 0.749 |
| LIG_LIR_Gen_1 | 46 | 57 | PF02991 | 0.559 |
| LIG_LIR_LC3C_4 | 12 | 15 | PF02991 | 0.680 |
| LIG_LIR_Nem_3 | 155 | 160 | PF02991 | 0.684 |
| LIG_LIR_Nem_3 | 46 | 52 | PF02991 | 0.565 |
| LIG_LIR_Nem_3 | 54 | 60 | PF02991 | 0.583 |
| LIG_PTB_Apo_2 | 36 | 43 | PF02174 | 0.637 |
| LIG_SH2_STAP1 | 45 | 49 | PF00017 | 0.627 |
| LIG_SH2_STAT3 | 45 | 48 | PF00017 | 0.672 |
| LIG_SUMO_SIM_anti_2 | 197 | 204 | PF11976 | 0.598 |
| LIG_UBA3_1 | 203 | 211 | PF00899 | 0.415 |
| LIG_WRC_WIRS_1 | 52 | 57 | PF05994 | 0.664 |
| MOD_CK2_1 | 119 | 125 | PF00069 | 0.623 |
| MOD_CK2_1 | 128 | 134 | PF00069 | 0.543 |
| MOD_CK2_1 | 178 | 184 | PF00069 | 0.705 |
| MOD_CK2_1 | 204 | 210 | PF00069 | 0.651 |
| MOD_Cter_Amidation | 19 | 22 | PF01082 | 0.644 |
| MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.741 |
| MOD_GlcNHglycan | 181 | 184 | PF01048 | 0.727 |
| MOD_GlcNHglycan | 63 | 66 | PF01048 | 0.627 |
| MOD_GSK3_1 | 108 | 115 | PF00069 | 0.707 |
| MOD_GSK3_1 | 116 | 123 | PF00069 | 0.609 |
| MOD_GSK3_1 | 175 | 182 | PF00069 | 0.745 |
| MOD_N-GLC_1 | 119 | 124 | PF02516 | 0.675 |
| MOD_NEK2_1 | 103 | 108 | PF00069 | 0.753 |
| MOD_NEK2_1 | 204 | 209 | PF00069 | 0.614 |
| MOD_NEK2_1 | 219 | 224 | PF00069 | 0.518 |
| MOD_NEK2_1 | 23 | 28 | PF00069 | 0.657 |
| MOD_NEK2_1 | 61 | 66 | PF00069 | 0.622 |
| MOD_Plk_1 | 119 | 125 | PF00069 | 0.674 |
| MOD_Plk_1 | 91 | 97 | PF00069 | 0.650 |
| MOD_Plk_4 | 112 | 118 | PF00069 | 0.723 |
| MOD_Plk_4 | 51 | 57 | PF00069 | 0.657 |
| MOD_Plk_4 | 9 | 15 | PF00069 | 0.696 |
| MOD_Plk_4 | 91 | 97 | PF00069 | 0.693 |
| MOD_ProDKin_1 | 108 | 114 | PF00069 | 0.622 |
| MOD_SUMO_rev_2 | 132 | 138 | PF00179 | 0.593 |
| MOD_SUMO_rev_2 | 26 | 33 | PF00179 | 0.693 |
| TRG_DiLeu_BaEn_1 | 134 | 139 | PF01217 | 0.660 |
| TRG_DiLeu_BaLyEn_6 | 98 | 103 | PF01217 | 0.629 |
| TRG_ER_diArg_1 | 21 | 23 | PF00400 | 0.727 |
| TRG_ER_diArg_1 | 227 | 229 | PF00400 | 0.715 |
| TRG_ER_diArg_1 | 88 | 90 | PF00400 | 0.584 |
| TRG_ER_diArg_1 | 99 | 102 | PF00400 | 0.613 |
| TRG_NLS_Bipartite_1 | 84 | 103 | PF00514 | 0.596 |
| TRG_NLS_MonoCore_2 | 96 | 101 | PF00514 | 0.648 |
| TRG_NLS_MonoExtC_3 | 96 | 101 | PF00514 | 0.608 |
| TRG_NLS_MonoExtN_4 | 97 | 103 | PF00514 | 0.650 |
| TRG_Pf-PMV_PEXEL_1 | 158 | 162 | PF00026 | 0.638 |
| TRG_Pf-PMV_PEXEL_1 | 59 | 63 | PF00026 | 0.602 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I083 | Leptomonas seymouri | 61% | 97% |
| A0A1X0NT13 | Trypanosomatidae | 44% | 96% |
| A0A3R7KLV2 | Trypanosoma rangeli | 44% | 92% |
| A4H8V1 | Leishmania braziliensis | 75% | 100% |
| A4HX70 | Leishmania infantum | 99% | 100% |
| C9ZTU2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 100% |
| E9ARC7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
| Q4QEJ3 | Leishmania major | 92% | 100% |